Introduction: A debate exists whether patients after second graft loss should be considered for a third and subsequent graft. Hence, a retrospective analysis was undertaken to assess outcomes of patients who underwent third and fourth transplantation. Materials and Methods: A total number of 16 kidney transplantations, were included in the present study. Thirteen patients out of them underwent a third kidney transplantation and 3 were fourth graft recipients. Data and variables on patient and graft survival were retrieved and analyzed using Kaplan-Meier statistics. Postoperative complications were assessed and graded based on Clavien-Dindo classification. Results: Patient survival was 92.3% after 1 year and 76.9% after 5 years (third graft). One year censored graft survival was 100% and a 5-year graft survival was 74.1% (third graft), respectively. In the cases of fourth transplantation, graft survivals of 33.3% at 1 and 2 years were noted among 3 patients. All fourth graft recipients have survived during our observation time. The overall rate of postoperative surgical complications among third graft recipients was 46.2 and 66.7% among patients after fourth transplantation. Conclusions: Results on third kidney transplantation showed satisfactory patient and graft survival with acceptable outcome.

Keywords:
Fourth kidney transplantation, Retransplantation, Surgical complications, Third kidney transplantation
1.
Kousoulas L, et al: Risk-adjusted analysis of relevant outcome drivers for patients after more than two kidney transplants. J Transplant 2015;2015:712049.
2.
Loupy A, et al: Long-term outcome of third kidney transplants. Nephrol Dial Transplant 2007;22:2693-2700.
3.
Lamb KE, Lodhi S, Meier-Kriesche HU: Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant 2011;11:450-462.
4.
Meier-Kriesche HU, Schold JD, Kaplan B: Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 2004;4:1289-1295.
5.
Meier-Kriesche HU, et al: Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004;4:378-383.
6.
Fasola CG, et al: Kidney retransplantation: patients with a failed second kidney transplant should be considered for a third transplant. Transplant Proc 1991;23(1 pt 2):1336.
7.
Kim HS, et al: Immunologic and non-immunologic complications of a third kidney transplantation. Korean J Intern Med 2015;30:657-664.
8.
Marcén R, Teruel JL: Patient outcomes after kidney allograft loss. Transplant Rev (Orlando) 2008;22:62-72.
9.
Coupel S, et al: Ten-year survival of second kidney transplants: impact of immunologic factors and renal function at 12 months. Kidney Int 2003;64:674-680.
10.
Hornberger JC, Best JH, Garrison LP Jr: Cost-effectiveness of repeat medical procedures: kidney transplantation as an example. Med Decis Making 1997;17:363-372.
11.
Matas AJ, et al: A third kidney transplant: cost-effective treatment for end-stage renal disease? Clin Transplant 1996;10(6 pt 1):516-520.
12.
Izquierdo L, et al: Third and fourth kidney transplant: still a reasonable option. Transplant Proc 2010;42:2498-2502.
13.
Reboux AH, et al: A third renal transplantation: is it relevant and is it worth it? Transplant Proc 2005;37:4199-4202.
14.
Loupy A, et al: Impact of surgical procedures and complications on outcomes of third and subsequent kidney transplants. Transplantation 2007;83:385-391.
15.
Hagan C, Hickey DP, Little DM: A single-center study of the technical aspects and outcome of third and subsequent renal transplants. Transplantation 2003;75:1687-1691.
16.
Kienzl-Wagner K, et al: Single-center experience with third and fourth kidney transplants. Transpl Int 2011;24:780-786.
17.
Gutiérrez Baños JL, et al: Surgical aspects in the third and fourth kidney retransplant. Actas Urol Esp 2005;29:212-216.
18.
Mazzucchi E, et al: Surgical aspects of third and subsequent renal transplants performed by the extraperitoneal access. Transplantation 2006;81:840-844.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.